Duvall Diantha Insider Profile

4 Followers
Duvall Diantha, CAO at Bioverativ Inc, holds 6.62K shares in Genocea Biosciences (Ticker: GNCA), holds 0.00 shares in Bioverativ Inc (Ticker: BIVV).
tipranks
Duvall Diantha

Duvall Diantha
Bioverativ Inc (BIVV)
CAO

Not Ranked
Duvall Diantha has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$14K
100.00%
A breakdown of Duvall Diantha's holdings

Insider Roles

Genocea Biosciences
(GNCA)
CFO
Roles that Duvall Diantha holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Duvall Diantha

Duvall Diantha's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BIVV
Bioverativ Inc
Mar 08, 2018
Uninformative Sell
$0.00
Genocea Biosciences
Jun 02, 2020
CFO
Uninformative Buy
$13.78K
List of latest transactions for each holding click on a transaction to see Duvall Diantha's performance on stock

Duvall Diantha insider profile FAQ

What is the percentage of profitable transactions made by Duvall Diantha?
The percentage of profitable transactions made by Duvall Diantha is ―.
    What is the average return per transaction made by Duvall Diantha?
    The average return per transaction made by Duvall Diantha is ―.
      What stocks does Duvall Diantha hold?
      Duvall Diantha holds: BIVV, GNCA stocks.
        What was Duvall Diantha’s latest transaction?
        Duvall Diantha latest transaction was an Uninformative Buy of ―.
          What was Duvall Diantha's most profitable transaction?
          Duvall Diantha’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Duvall Diantha's role in Bioverativ Inc?
            Duvall Diantha's role in Bioverativ Inc is CAO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.